Zacks Investment Research downgraded shares of MEDICAL ACTION (MDCI) from OUTPERFORM to NEUTRAL on April 15, 2013, with a target price of $6.50.
Medical Action Industries develops, manufactures, markets and distributes a variety of disposable surgical related products. Through its existing direct sales force, manufacturers' representatives and internal sales department, their products are sold throughout the United States and certain international markets, and is expanding their end-user base to include physician, dental and veterinary offices.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on MEDICAL ACTION (MDCI),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment